Caregiver-Oncologist Prognostic Concordance, Caregiver Mastery, and Caregiver Psychological Health and Quality of Life.
Caregivers
Depressive symptoms
Environmental mastery
Older patients
Prognostic concordance
Journal
The oncologist
ISSN: 1549-490X
Titre abrégé: Oncologist
Pays: England
ID NLM: 9607837
Informations de publication
Date de publication:
04 2021
04 2021
Historique:
received:
03
10
2020
accepted:
22
01
2021
pubmed:
2
2
2021
medline:
22
6
2021
entrez:
1
2
2021
Statut:
ppublish
Résumé
Caregivers of adults with cancer often report a different understanding of the patient's prognosis than the oncologist. We examine the associations of caregiver-oncologist prognostic concordance with caregiver depressive symptoms, distress, and quality of life (QoL). We also explore whether these relationships differed by caregiver environment mastery, an individual's sense of control, and effectiveness in managing life situations. We used data from a national geriatric assessment cluster-randomized trial (URCC 13070) that recruited patients aged 70 years and older with incurable cancer considering any line of cancer treatment at community oncology practices, their caregivers, and their oncologists. At enrollment, caregivers and oncologists estimated the patient's prognosis (0-6 months, 7-12 months, 1-2 years, 2-5 years, and >5 years; identical responses were concordant). Caregivers completed the Ryff's environmental mastery at enrollment. At 4-6 weeks, caregivers completed the Patient Health Questionnaire-2 (depressive symptoms), distress thermometer, and 12-Item Short-Form Health Survey (quality of life [QoL]). We used generalized estimating equations in models adjusted for covariates. We then assessed the moderation effect of caregiver mastery. Of 411 caregiver-oncologist dyads (mean age = 66.5 years), 369 provided responses and 28% were concordant. Prognostic concordance was associated with greater caregiver depressive symptoms (β = 0.30; p = .04) but not distress or QoL. A significant moderation effect for caregiver depressive symptoms was found between concordance and mastery (p = .01). Specifically, among caregivers with low mastery (below median), concordance was associated with greater depressive symptoms (β = 0.68; p = .003). Caregiver-oncologist prognostic concordance was associated with caregiver depressive symptoms. We found a novel moderating effect of caregiver mastery on the relationship between concordance and caregiver depressive symptoms. Caregiver-oncologist prognostic concordance is associated with greater caregiver depressive symptoms, particularly in those with low caregiver mastery. When discussing prognosis with caregivers, physicians should be aware that prognostic understanding may affect caregiver psychological health and should assess their depressive symptoms. In addition, while promoting accurate prognostic understanding, physicians should also identify strengths and build resilience among caregivers.
Sections du résumé
BACKGROUND
Caregivers of adults with cancer often report a different understanding of the patient's prognosis than the oncologist. We examine the associations of caregiver-oncologist prognostic concordance with caregiver depressive symptoms, distress, and quality of life (QoL). We also explore whether these relationships differed by caregiver environment mastery, an individual's sense of control, and effectiveness in managing life situations.
MATERIALS AND METHODS
We used data from a national geriatric assessment cluster-randomized trial (URCC 13070) that recruited patients aged 70 years and older with incurable cancer considering any line of cancer treatment at community oncology practices, their caregivers, and their oncologists. At enrollment, caregivers and oncologists estimated the patient's prognosis (0-6 months, 7-12 months, 1-2 years, 2-5 years, and >5 years; identical responses were concordant). Caregivers completed the Ryff's environmental mastery at enrollment. At 4-6 weeks, caregivers completed the Patient Health Questionnaire-2 (depressive symptoms), distress thermometer, and 12-Item Short-Form Health Survey (quality of life [QoL]). We used generalized estimating equations in models adjusted for covariates. We then assessed the moderation effect of caregiver mastery.
RESULTS
Of 411 caregiver-oncologist dyads (mean age = 66.5 years), 369 provided responses and 28% were concordant. Prognostic concordance was associated with greater caregiver depressive symptoms (β = 0.30; p = .04) but not distress or QoL. A significant moderation effect for caregiver depressive symptoms was found between concordance and mastery (p = .01). Specifically, among caregivers with low mastery (below median), concordance was associated with greater depressive symptoms (β = 0.68; p = .003).
CONCLUSIONS
Caregiver-oncologist prognostic concordance was associated with caregiver depressive symptoms. We found a novel moderating effect of caregiver mastery on the relationship between concordance and caregiver depressive symptoms.
IMPLICATIONS FOR PRACTICE
Caregiver-oncologist prognostic concordance is associated with greater caregiver depressive symptoms, particularly in those with low caregiver mastery. When discussing prognosis with caregivers, physicians should be aware that prognostic understanding may affect caregiver psychological health and should assess their depressive symptoms. In addition, while promoting accurate prognostic understanding, physicians should also identify strengths and build resilience among caregivers.
Identifiants
pubmed: 33523583
doi: 10.1002/onco.13699
pmc: PMC8018313
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
310-317Subventions
Organisme : NCI NIH HHS
ID : R00 CA237744
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA008748
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA168387
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG022845
Pays : United States
Organisme : NCI NIH HHS
ID : K99 CA237744
Pays : United States
Organisme : NCI NIH HHS
ID : UG1 CA189961
Pays : United States
Organisme : NIA NIH HHS
ID : R33 AG059206
Pays : United States
Organisme : NIA NIH HHS
ID : K76 AG064394
Pays : United States
Organisme : NIA NIH HHS
ID : K24 AG056589
Pays : United States
Informations de copyright
© 2021 AlphaMed Press.
Références
Med Care. 1996 Mar;34(3):220-33
pubmed: 8628042
Clin Lung Cancer. 2019 May;20(3):e369-e375
pubmed: 30635259
J Pain Symptom Manage. 2020 Jul;60(1):20-27
pubmed: 32061833
J Geriatr Oncol. 2020 Mar;11(2):217-224
pubmed: 31628066
J Support Oncol. 2004 Mar-Apr;2(2):145-55
pubmed: 15328817
J Palliat Med. 2006 Feb;9(1):61-9
pubmed: 16430346
J Clin Oncol. 2018 Jan 1;36(1):53-60
pubmed: 29140772
J Nutr Health Aging. 2018;22(10):1238-1245
pubmed: 30498832
Bone Marrow Transplant. 2015 Aug;50(8):1119-24
pubmed: 25961772
Cancer. 2019 Aug 1;125(15):2684-2692
pubmed: 31034597
Prog Cardiovasc Nurs. 2008 Winter;23(1):18-26
pubmed: 18326990
Oncologist. 2019 Jun;24(6):e292-e302
pubmed: 31015317
J Clin Oncol. 2017 Aug 1;35(22):2551-2557
pubmed: 28574777
J Clin Oncol. 2011 Jun 10;29(17):2319-26
pubmed: 21555700
J Nurs Scholarsh. 2007;39(3):249-55
pubmed: 17760798
Health Psychol. 2009 Mar;28(2):147-56
pubmed: 19290706
Cancer. 2017 Nov 15;123(22):4481-4487
pubmed: 28727147
J Clin Oncol. 2004 May 1;22(9):1721-30
pubmed: 15117995
J Clin Oncol. 2016 Feb 20;34(6):557-65
pubmed: 26644527
Psychooncology. 2018 Jan;27(1):106-113
pubmed: 28603876
J Am Geriatr Soc. 2019 May;67(5):969-977
pubmed: 30924548
Cancer. 2014 Jan 15;120(2):278-85
pubmed: 24122784
Aging Ment Health. 2012;16(1):27-38
pubmed: 22224706
Oncologist. 2017 Nov;22(11):1383-1391
pubmed: 28808093
J Clin Oncol. 2021 Mar 1;39(7):734-747
pubmed: 33417506
J Clin Oncol. 2015 Nov 10;33(32):3809-16
pubmed: 26438121
JAMA Netw Open. 2020 Apr 1;3(4):e202583
pubmed: 32282044
Nat Rev Clin Oncol. 2020 Dec;17(12):742-755
pubmed: 32879429
Ann Oncol. 2020 Jan;31(1):123-130
pubmed: 31912785
J Palliat Med. 2018 Mar;21(S2):S17-S27
pubmed: 29091522
World J Psychiatry. 2013 Sep 22;3(3):65-73
pubmed: 24255878
Cancer. 2001 Mar 1;91(5):1029-39
pubmed: 11251956
Contemp Clin Trials Commun. 2019 Nov 12;16:100485
pubmed: 31768470
J Am Geriatr Soc. 2019 May;67(5):998-1004
pubmed: 30848838
J Cancer Educ. 2014 Jun;29(2):311-7
pubmed: 24402976
Cancer. 2019 Jul 15;125(14):2506-2513
pubmed: 30920646
J Clin Oncol. 2009 Sep 10;27(26):4346-51
pubmed: 19652074
Semin Oncol Nurs. 2012 Nov;28(4):221-5
pubmed: 23107179
Med Care. 2003 Nov;41(11):1284-92
pubmed: 14583691
Asian Nurs Res (Korean Soc Nurs Sci). 2009 Dec;3(4):154-66
pubmed: 25030627
PLoS One. 2019 Mar 13;14(3):e0212967
pubmed: 30865681
Oncologist. 2018 Oct;23(10):1218-1229
pubmed: 30120158
JAMA. 2008 Oct 8;300(14):1665-73
pubmed: 18840840
J Geriatr Oncol. 2020 Jan;11(1):75-81
pubmed: 30952516